Nanobiotix S.A. NANO
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Nanobiotix S.A. is a late-stage clinical biotechnology company specializing in physics-based nanomedicines to revolutionize cancer treatment. Headquartered in Paris, France, with offices in the United States, it pioneers nanotechnology that enhances radiotherapy's efficacy. The company's lead candidate, NBTXR3 (markete…
SectorHealthcare
ExchangeXPAR
IndustryBiotechnology
CountryFrance
Employees108
TickerNANO
Statistics
Market Cap$1.72B
Revenue (TTM)$34.7M
Net Income—
Net Margin—
EPS—
P/E—
P/S49.61
P/B—
EV/EBITDA-150.94
ROE28.4%
Dividend Yield—
Price$35.62
Data: Twelve Data · Revenue = mcap / P/S